The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 17:496-502, November 2005
doi: 10.1176/appi.neuropsych.17.4.496
© 2005 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Paulsen, J. S.
* Articles by Turner, B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Paulsen, J. S.
* Articles by Turner, B.
Related Collections
* Depression
* Huntington's Disease

Depression and Stages of Huntington’s Disease

Jane S. Paulsen, Ph.D., Carissa Nehl, B.S., Karin Ferneyhough Hoth, M.A., Jason E. Kanz, M.S., Michelle Benjamin, B.S., Rachel Conybeare, B.S., Bradley McDowell, Ph.D. and Beth Turner, B.S.The Huntington Study Group

Received March 9, 2004; revised May 25, 2004; accepted June 18, 2004. From the University of Iowa School of Medicine, Department of Psychiatry, Iowa City, Iowa. Address correspondence to Dr. Paulsen, Ph.D., University of Iowa, 1-305 Medical Education Building, Iowa City, IA 52242; jane-paulsen{at}uiowa.edu (E-mail).

Individuals with manifest Huntington’s disease (HD) were interviewed with regard to the presence, frequency, and severity of depression symptoms to better characterize depressed mood across the disease course in HD. Rates of depression were more than twice that found in the general population. One-half reported that they had sought treatment for depression, and more than 10% reported having at least one suicide attempt. The proportion of HD patients endorsing significant depression diminished with disease progression. Despite the public health impact of depression, available treatments are underutilized in HD, and research is needed to document the efficacy and effectiveness of standard depression treatments in this population.




This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
E. van Duijn, E.M. Kingma, and R.C. van der Mast
Psychopathology in Verified Huntington's Disease Gene Carriers
J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 441 - 448.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org